DEXCOM INC Quarterly Deferred State and Local Income Tax Expense (Benefit) in USD for Q4 2017
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Dexcom Inc annual/quarterly Deferred State and Local Income Tax Expense (Benefit) history and growth rate for Q4 2017.
- Dexcom Inc Deferred State and Local Income Tax Expense (Benefit) for the quarter ending December 31, 2017 was $0.000.
- Dexcom Inc annual Deferred State and Local Income Tax Expense (Benefit) for 2023 was $14.6M.
- Dexcom Inc annual Deferred State and Local Income Tax Expense (Benefit) for 2022 was -$17.6M, a 8700% decline from 2021.
- Dexcom Inc annual Deferred State and Local Income Tax Expense (Benefit) for 2021 was -$200K, a 99.6% increase from 2020.
Deferred State and Local Income Tax Expense (Benefit), Quarterly (USD)